Gain Therapeutics 新闻与活动
高管
查看带有其 22 名主要高管的组织结构图
Gain Therapeutics 搜索最多的简介
- Gene Mack, Chief Executive Officer and President
- Jeffrey Riley, Head, Biology
- Hans Peter Hasler, Independent Member
高管在Gain Therapeutics变化
- Gene Mack 曾任 Chief Financial Officer and Interim Chief Executive Officer, 现任 Chief Executive Officer and President (新闻发布的2025一月7号).
- Gianluca Fuggetta 曾任 Vice President, Finance, 现升职为 Senior Vice President Finance (新闻发布的2025一月7号).
创建提醒
跟踪 Gain Therapeutics 的高管变动
生物技术
Gain Therapeutics 拥有 2,350 家竞争者，其中包括 Incyte (美国(美洲))、Anthos Therapeutics (美国(美洲)) 和 Valneva (法国)。
Popular M&A news in 生物技术
- CoRegen 刚刚宣布为 93 筹款数百万美元。 (公布2025七月11号).
- Actithera 刚刚宣布为 75 筹款数百万美元。 (公布2025七月10号).
- Centivax 刚刚宣布为 45 筹款数百万美元。 (公布2025七月10号).
生物技术 行业的其他推荐联系人
消息
Gain Therapeutics 的最新新闻稿
- Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
- Gain Therapeutics to Participate in Upcoming Investor Conferences
- Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting
- Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
- Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update
- Gain Therapeutics to Participate at The Citizens Life Sciences Conference
- Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
- Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update
- Gain Therapeutics Announces Poster Presentation at AD/PD 2025
- Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
- View more press releases Close
